Literature DB >> 17634861

Quantitative evaluation of reduction of plaque-like hard exudates in diabetic macular edema after intravitreal triamcinolone injection.

Osman Cekiç1, Yavuz Bardak, U Sahin Tiğ, Uzeyir Yildizoğlu, Handan Bardak.   

Abstract

BACKGROUND: To describe a new method of quantifying the amount of plaque-like hard exudates after intravitreal triamcinolone acetonide injection in diabetic macular edema.
METHODS: This study included 22 eyes of 14 patients (mean age, 63 years) with chronic diabetic macular edema and plaque-like hard exudates. The patients were injected with a single dose of 4 mg intravitreal triamcinolone acetonide. The optic disc size as relative size unit was taken to quantify the hard exudates: Total areas of exudates and the optic nerve head were computed from fundus pictures with a digital analysis program on magnified images. The former was divided by the latter, and the results were expressed as a percentage value. The ratio was used to track improvements in a given eye over 6 months.
RESULTS: Average ratio of hard exudates to optic nerve head area reduced to 81% of its initial value at 1 month (P=0.007), to 54% at 3 months (P<0.001) and to 41% at 6 months (P<0.001).
CONCLUSIONS: The new method allowed detection of a significant reduction of ratio of hard exudates to optic disc area of diabetic plaque-like hard exudates following 4 mg intravitreal triamcinolone.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17634861     DOI: 10.1007/s10792-007-9120-3

Source DB:  PubMed          Journal:  Int Ophthalmol        ISSN: 0165-5701            Impact factor:   2.031


  8 in total

1.  The relation between visual acuity, fixation stability, and the size and location of foveal hard exudates after photocoagulation for diabetic maculopathy: a 1-year follow-up study.

Authors:  F Møller; T Bek
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2003-05-15       Impact factor: 3.117

2.  Intravitreal triamcinolone for the treatment of refractory diabetic macular oedema with hard exudates: an optical coherence tomography study.

Authors:  A P Ciardella; J Klancnik; W Schiff; G Barile; K Langton; S Chang
Journal:  Br J Ophthalmol       Date:  2004-09       Impact factor: 4.638

3.  [Digital analysis of the optic disc with fundus camera: a study of variability].

Authors:  P Gili Manzanaro; C Carrasco Font; J C Martín Rodrigo; J Yangüela Rodilla; A Arias Puente
Journal:  Arch Soc Esp Oftalmol       Date:  2004-03

4.  Age-related macular degeneration and optic disk morphology.

Authors:  W M Budde; J B Jonas; U Schönherr
Journal:  Am J Ophthalmol       Date:  1999-02       Impact factor: 5.258

5.  Intravitreal triamcinolone injection for treatment of macular edema secondary to branch retinal vein occlusion.

Authors:  Osman Cekiç; Stanley Chang; Joseph J Tseng; Gaetano R Barile; Lucian V Del Priore; Harold Weissman; William M Schiff; Michael D Ober
Journal:  Retina       Date:  2005 Oct-Nov       Impact factor: 4.256

6.  Primary intravitreal triamcinolone acetonide for diabetic massive macular hard exudates.

Authors:  Moncef Khairallah; Hatem Zeghidi; Ahmed Ladjimi; Salim Ben Yahia; Sonia Attia; Sonia Zaouali; Riadh Messaoud
Journal:  Retina       Date:  2005 Oct-Nov       Impact factor: 4.256

7.  Variability of the real dimensions of normal human optic discs.

Authors:  J B Jonas; G C Gusek; I Guggenmoos-Holzmann; G O Naumann
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1988       Impact factor: 3.117

8.  Intravitreal triamcinolone injection for chronic diabetic macular oedema with severe hard exudates.

Authors:  Remzi Avci; Berkant Kaderli
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2005-07-21       Impact factor: 3.117

  8 in total
  6 in total

1.  Vessel diameter study: intravitreal vs posterior subtenon triamcinolone acetonide injection for diabetic macular edema.

Authors:  M M Kurt; O Çekiç; Ç Akpolat; M Aslankurt; M Elçioğlu
Journal:  Eye (Lond)       Date:  2017-03-24       Impact factor: 3.775

2.  Retinal Sensitivity over Hard Exudates in Diabetic Retinopathy.

Authors:  Rajiv Raman; Muneeswar Gupta Nittala; Laxmi Gella; Swakshyar Saumya Pal; Tarun Sharma
Journal:  J Ophthalmic Vis Res       Date:  2015 Apr-Jun

3.  Effect of grape seed proanthocyanidin extract on hard exudates in patients with non-proliferative diabetic retinopathy.

Authors:  Sang Woong Moon; Yong Un Shin; Heeyoon Cho; So Hyun Bae; Ha Kyoung Kim
Journal:  Medicine (Baltimore)       Date:  2019-05       Impact factor: 1.817

4.  Diabetic macular edema treatment guidelines in India: All India Ophthalmological Society Diabetic Retinopathy Task Force and Vitreoretinal Society of India consensus statement.

Authors:  Sneha Giridhar; Lalit Verma; Anand Rajendran; Muna Bhende; Mallika Goyal; Kim Ramasamy; R Padmaja; Sundaram Natarajan; Mahesh Shanmugam Palanivelu; Rajiv Raman; Sobha Sivaprasad
Journal:  Indian J Ophthalmol       Date:  2021-11       Impact factor: 1.848

5.  Quantitative evaluation of hard exudates in diabetic macular edema after short-term intravitreal triamcinolone, dexamethasone implant or bevacizumab injections.

Authors:  Yong Un Shin; Eun Hee Hong; Han Woong Lim; Min Ho Kang; Mincheol Seong; Heeyoon Cho
Journal:  BMC Ophthalmol       Date:  2017-10-03       Impact factor: 2.209

6.  Vitrectomy with internal limiting membrane peeling versus nonsurgical treatment for diabetic macular edema with massive hard exudates.

Authors:  Hsuan-Chieh Lin; Chung-May Yang; San-Ni Chen; Yi-Ting Hsieh
Journal:  PLoS One       Date:  2020-07-31       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.